Target intelligence / Profile preview

U6 spliceosomal RNA (U6 snRNA)

Target
U6 snRNA
Molecular classification
Small nuclear RNA (snRNA), Non-coding RNA, Component of the spliceosome, Other
01

Overview

U6 spliceosomal RNA (U6 snRNA) is a highly conserved, non-coding, small nuclear RNA that functions as an essential component of the spliceosome, the ribonucleoprotein complex responsible for excising introns from precursor mRNA (pre-mRNA) in the nucleus of eukaryotic cells[1][2][4][5]. It forms part of the U6 small nuclear ribonucleoprotein (snRNP), dynamically interacting with U4, U2, and U5 snRNAs and numerous proteins throughout the stepwise assembly and catalytic activation of the spliceosome[1][3][5]. U6 snRNA is directly involved in the catalytic steps of splicing, coordinating catalytic metal ions and forming key base-pairing interactions that define the active site of the spliceosome[1][2][5][7]. Its sequence and structure are the most conserved among the five spliceosomal snRNAs, underscoring its fundamental and universal role in gene expression[2][4][8]. While disruption of U6 snRNA function is lethal to cells, there are currently no clinically approved drugs that target this RNA molecule directly for therapeutic purposes. Note: U6 snRNA is not considered a classical "therapeutic target" like a receptor, enzyme, or transporter because it is a structural and catalytic RNA essential for basic cellular function, and its inhibition would be incompatible with viability[1][2].

Other names
U6 snRNAU6 small nuclear RNAU6LOC124902333U6 spliceosomal RNA
02

Biological functions

Catalysis of pre-mRNA splicingFormation of the catalytic core of the spliceosomeRNA-RNA and RNA-protein interactions within spliceosomeRNA structural rearrangementsOther
03

Disease associations

Other (no direct disease association as a classical therapeutic target, but critical for cellular RNA processing and viability)
04

Safety considerations

Essential for cell viability (global inhibition likely cytotoxic)Off-target modulation could disrupt all mRNA splicing

Beyond the preview

Go deeper on U6 spliceosomal RNA (U6 snRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 spliceosomal RNA (U6 snRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call